Biowaivers

The Guideline on the Investigation of Bioequivalence (CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **) provides criteria for when a drug or drug strength does not need to undergo a bioequivalence study. These requirements are extensive and DADA has experts capable of evaluating your product and writing a biowaiver where applicable.